Addus HomeCare Corporation

Addus HomeCare Corporation

ADUSNYSE / NASDAQHealthcareSmall cap

$122.50+$1.43 (+1.2%)

Last close · Data as of Nov 20, 2026

Market cap
$1.7B
P/E
17.5x
EV / EBITDA
11.2x
Revenue
$1.4B
Net margin
6.7%
ROCE
10.8%

+11.3% over the last year

Addus HomeCare Corporation price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
+3.8%
3M
+1.6%
6M
+30.7%
1Y
+11.3%
5Y
+22.0%

52-week range

Day change +$1.43 (+1.2%) from $121 to $123 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in ADUS, bought on each weekday since 2021.

News & filings

What Addus HomeCare filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

StrengthOperating profit was 10.4 times interest costs.

Concerns (1)

  • Return on equity of 8.8%.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living.

Read moreShow less

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

Sector
Healthcare
Shares outstanding
18.5M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$1.7B
P/E
17.5x
P/B
1.5x
EV / EBITDA
11.2x
EV / Sales
1.2x
P/S
1.2x
52-week high
$127.94
52-week low
$88.49

Profitability

Operating margin
9.7%
Net margin
6.7%
EBITDA margin
11.1%
ROE
8.8%
ROCE
10.8%
ROA
6.7%
Asset turnover
0.99

Growth

Revenue
$1.4B
Revenue growth, 1Y
23.2%
Revenue CAGR, 3Y
14.4%
Net profit growth, 1Y
30.3%
Free cash flow
$103.8M

Solvency

Current ratio
1.80
Debt / Equity
0.16
Debt / Assets
0.12
CFO / Net profit
1.16
Cash / Market cap
4.9%

Where the revenue went

Of every $100 of FY2025 revenue, $7 was left as net income.

Addus HomeCare Corporation income statement flow, FY2025
Addus HomeCare Corporation income statement flow, FY2025: flows
FromToAmount
RevenueCost of revenue$960.7M
RevenueGross profit$461.9M
Gross profitSelling, general and administrative$306.9M
Gross profitOther operating expenses$16.4M
Gross profitOperating income$138.6M
Operating incomePretax income$127.4M
Operating incomeInterest and other expense$11.2M
Pretax incomeTax and other$31.5M
Pretax incomeNet income$95.9M

Revenue and net profit

Revenue grew 23.2% in FY2025; net profit is the dashed line.

Addus HomeCare Corporation revenue and net profit by fiscal year
Addus HomeCare Corporation revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$951.1M$46.0M
FY2023$1.1B$62.5M
FY2024$1.2B$73.6M
FY2025$1.4B$95.9M

Cash flows

FY2025: $111.5M from operations, $103.8M free after investment (dashed).

Addus HomeCare Corporation operating and free cash flow by fiscal year
Addus HomeCare Corporation operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$105.1M$96.8M
FY2023$112.2M$102.8M
FY2024$116.4M$110.4M
FY2025$111.5M$103.8M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$1.4B+23.2%1Y
EBITDA
$157.5M+30.6%1Y
Net profit
$95.9M+30.3%1Y
Cash from operations
$111.5M-4.2%1Y
Free cash flow
$103.8M-6.0%1Y
Revenue CAGR, 3Y
14.4%
Net profit CAGR, 3Y
27.7%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$1.4B$157.5M$95.9M$103.8M8.8%+23.2%+30.3%

Monthly returns

Month-by-month returns of ADUS across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$1.4B
Liabilities$352.0M
Equity$1.1B
Paid-in capital$613.0M
Retained earnings$472.3M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; ADUS highlighted.

P/E against peers

ADUS trades at 17.5x earnings against a peer median of -9.8x.

  1. Addus HomeCare Corporation (this company)17.5x

EV / Sales, for the companies without earnings

Not shown (no positive earnings and no EV / Sales): Biohaven Ltd., Sionna Therapeutics, Inc., Palvella Therapeutics, Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Addus HomeCare CorporationADUSthis company$1.7B17.5x1.5x8.8%11.2x
Biohaven Ltd.BHVN$1.7B-2.3x33.0x-1418.8%-2.4x
Agios Pharmaceuticals, Inc.AGIO$1.7B-4.1x1.4x-34.6%-3.6x
Sionna Therapeutics, Inc.SION$1.7B-22.7x5.6x-24.5%-18.7x
Taysha Gene Therapies, Inc.TSHA$1.7B-15.5x6.9x-44.1%-13.4x
Novavax, Inc.NVAX$1.7B3.8x-13.1x-344.7%3.4x
GeneDx Holdings Corp.WGS$1.7B-79.5x5.4x-6.8%138.2x
Palvella Therapeutics, Inc.PVLA$1.6B-39.5x58.9x-149.1%-44.3x
Innoviva, Inc.INVA$1.6B6.0x1.4x23.1%3.7x
Peer median—-9.8x5.5x-39.4%-3.0x

Year-to-date ROI

ADUS since 1 January, against earlier years.

Historical volatility

ADUS's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Addus HomeCare Corporation operating margin by fiscal year
Addus HomeCare Corporation operating margin by fiscal year
DateOperating margin
FY20227.2%
FY20238.6%
FY20248.9%
FY20259.7%
LineFY2025
Cost of revenueCost Of Revenue$960.7M
Gross profitGross Profit$461.9M
Operating expensesOperating Expense$323.3M
Depreciation and amortisationDepreciation And Amortization In Income Statement$16.4M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$16.4M
Total expensesTotal Expenses$1.3B
Pretax incomePretax Income$127.4M

Learn while you research

Academy chapters picked for Addus HomeCare Corporation and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Growth Investing23% revenue growth is in the top tier, learn how to value growth.7 min read
  3. 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  4. 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  5. 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  6. 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →